ArticleFrontiers in immunology2025

Correction: Tumor-penetrating peptide boosts bispecific T-cell engager antitumor efficacy for the pancreatic cancer.

Frontiers Production OfficePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.